Episode Details

Immunotherapies hold enormous promise for treating cancers of various types, but the bad news is that while many patients may initially respond many will also become resistant. Valsamo Anagnostou, a cancer researcher at Johns Hopkins, is looking at tumor specific …

Assessing individual cancer characteristics is needed to determine resistance to new types of therapies, Elizabeth Tracey reports Read More »